Concepedia

Urs Baettig

UB

6

Publications

155

Citations

6

H-Index

1996

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis (United Kingdom)

Urs Baettig is an author at Novartis (Switzerland) specializing in drug discovery, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1996–2021

6

Publications

6

Tropisetron for the Prevention of Postoperative Nausea and Vomiting in Women Undergoing Gynecologic Surgery

Eli Alon, Roman Kocián, Philipp C. Nett et al. · Anesthesia & Analgesia · 1996 · 45 citations

Discovery of Icenticaftor (QBW251), a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator with Clinical Efficacy in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease

Darren Le Grand, Martin Gosling, Urs Baettig et al. · Journal of Medicinal Chemistry · 2021 · 35 citations · Full text

8-Aryl xanthines potent inhibitors of phosphodiesterase 5

Ruth Arnold, David Beer, Gurdip Bhalay et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 23 citations · Full text

, , +7

<scp>NVP</scp>‐<scp>QBE</scp>170: an inhaled blocker of the epithelial sodium channel with a reduced potential to induce hyperkalaemia

K. Coote, Derek Paisley, Sarah Czarnecki et al. · British Journal of Pharmacology · 2015 · 21 citations · Full text

2-Cycloalkyl phenoxyacetic acid CRTh2 receptor antagonists

David A. Sandham, Clive Aldcroft, Urs Baettig et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 18 citations · Full text

, , +6

Rows per page

1–5 of 6